Your browser is no longer supported. Please, upgrade your browser.
SILK [NASD]
Silk Road Medical, Inc
Index- P/E- EPS (ttm)-1.43 Insider Own2.10% Shs Outstand34.34M Perf Week5.84%
Market Cap1.62B Forward P/E- EPS next Y-0.86 Insider Trans-26.03% Shs Float33.18M Perf Month-2.07%
Income-48.10M PEG- EPS next Q-0.36 Inst Own- Short Float5.79% Perf Quarter-10.58%
Sales78.30M P/S20.70 EPS this Y37.10% Inst Trans-0.55% Short Ratio5.95 Perf Half Y-22.05%
Book/sh2.95 P/B16.02 EPS next Y31.70% ROA-26.70% Target Price67.50 Perf Year30.51%
Cash/sh3.97 P/C11.91 EPS next 5Y- ROE-42.30% 52W Range35.48 - 75.80 Perf YTD-24.94%
Dividend- P/FCF- EPS past 5Y- ROI-28.20% 52W High-37.64% Beta-
Dividend %- Quick Ratio9.40 Sales past 5Y- Gross Margin72.50% 52W Low33.23% ATR2.38
Employees281 Current Ratio10.10 Sales Q/Q16.90% Oper. Margin-57.40% RSI (14)44.98 Volatility5.21% 4.42%
OptionableYes Debt/Eq0.48 EPS Q/Q1.80% Profit Margin-61.40% Rel Volume0.52 Prev Close47.01
ShortableYes LT Debt/Eq0.48 EarningsMay 04 AMC Payout- Avg Volume323.14K Price47.27
Recom2.00 SMA200.49% SMA50-7.66% SMA200-17.96% Volume168,296 Change0.55%
Oct-01-20Downgrade Citigroup Buy → Neutral $58 → $71
Aug-21-20Initiated Piper Sandler Neutral $54
Jul-09-20Initiated SVB Leerink Outperform $51
May-27-20Initiated Citigroup Buy $50
Aug-20-19Initiated Argus Buy $52
Apr-29-19Initiated Stifel Buy $44
Apr-29-19Initiated JP Morgan Overweight $45
Apr-29-19Initiated BofA/Merrill Neutral $43
Apr-29-19Initiated BMO Capital Markets Outperform
May-17-21 01:17PM  
May-12-21 07:16AM  
May-10-21 12:51PM  
May-05-21 03:00AM  
May-04-21 07:20PM  
04:05PM  
02:30PM  
May-03-21 04:05PM  
Apr-20-21 04:05PM  
Apr-15-21 04:05PM  
Apr-02-21 12:11PM  
Mar-25-21 09:42AM  
07:08AM  
Mar-10-21 09:00AM  
06:20AM  
Mar-02-21 10:00AM  
Mar-01-21 06:45PM  
04:35PM  
04:05PM  
02:30PM  
Feb-26-21 12:09PM  
Feb-25-21 04:05PM  
Feb-16-21 04:05PM  
Feb-15-21 09:48PM  
Feb-13-21 03:30PM  
Feb-11-21 01:39PM  
Feb-08-21 07:00PM  
Feb-06-21 11:05PM  
Feb-05-21 03:55AM  
Feb-03-21 12:33PM  
Jan-28-21 11:05PM  
Jan-25-21 11:54PM  
Jan-23-21 11:45PM  
Jan-20-21 11:47PM  
Dec-28-20 08:23AM  
Dec-25-20 07:51AM  
Dec-18-20 01:06PM  
Dec-17-20 04:05PM  
Dec-03-20 04:05PM  
Dec-02-20 12:32PM  
Nov-13-20 08:24AM  
Nov-10-20 07:30PM  
05:35PM  
04:55PM  
04:05PM  
02:30PM  
Nov-06-20 11:49AM  
Nov-04-20 04:05PM  
Nov-03-20 12:31PM  
Oct-20-20 04:05PM  
Oct-12-20 01:00PM  
Oct-01-20 04:05PM  
Sep-21-20 04:05PM  
09:00AM  
Sep-04-20 08:00AM  
Aug-26-20 09:01PM  
Aug-21-20 09:32AM  
Aug-19-20 04:05PM  
Aug-05-20 10:15PM  
08:01PM  
04:05PM  
Jul-29-20 12:33PM  
Jul-23-20 04:35PM  
Jul-22-20 12:01PM  
Jul-09-20 04:05PM  
Jul-05-20 06:41PM  
Jul-03-20 07:18PM  
Jun-30-20 04:05PM  
Jun-16-20 03:09PM  
Jun-15-20 08:27PM  
Jun-05-20 10:17AM  
May-20-20 04:05PM  
May-08-20 08:39PM  
04:05PM  
May-06-20 12:52PM  
01:15AM  
May-05-20 04:22PM  
May-01-20 11:30AM  
Apr-30-20 04:05PM  
Apr-29-20 04:05PM  
Apr-27-20 08:42AM  
Apr-26-20 07:50PM  
Apr-23-20 12:32PM  
Apr-21-20 06:15PM  
Apr-06-20 08:00AM  
Mar-20-20 03:15PM  
Mar-06-20 08:49AM  
Mar-05-20 10:00PM  
Mar-01-20 09:50AM  
Feb-28-20 12:00PM  
Feb-26-20 04:05PM  
Feb-13-20 04:05PM  
Jan-30-20 04:28PM  
Jan-10-20 02:53PM  
Jan-03-20 10:15AM  
Dec-27-19 09:17AM  
Dec-26-19 09:53AM  
Dec-19-19 04:05PM  
Dec-17-19 05:01PM  
04:08PM  
Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products includes ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LASERSOHN JACK WDirectorJun 03Sale45.605,427247,4714,769Jun 04 05:53 PM
Davis Andrew S.Chief Commercial OfficerJun 01Option Exercise3.916,32424,72635,907Jun 02 09:26 PM
Davis Andrew S.Chief Commercial OfficerJun 01Sale47.236,324298,66031,240Jun 02 09:26 PM
Buchanan Lucas W.COO/CFOMay 26Option Exercise20.0010,000200,000191,772May 28 07:12 PM
Buchanan Lucas W.COO/CFOMay 26Sale47.5610,000475,572181,772May 28 07:12 PM
Rogers Erica J.President and CEOMay 11Option Exercise1.6011,00017,600142,616May 12 09:38 PM
Rogers Erica J.President and CEOMay 11Sale48.6511,000535,197131,616May 12 09:38 PM
Buchanan Lucas W.COO/CFOMay 05Option Exercise1.605,0008,000181,772May 07 06:39 PM
Davis Andrew S.Chief Commercial OfficerMay 03Option Exercise1.606,32410,11837,564May 04 08:55 PM
Davis Andrew S.Chief Commercial OfficerMay 03Sale62.056,324392,42531,240May 04 08:55 PM
Buchanan Lucas W.COO/CFOApr 28Option Exercise13.1910,000131,917185,445Apr 30 08:28 PM
Buchanan Lucas W.COO/CFOApr 28Sale61.4310,000614,334176,772Apr 30 08:28 PM
Rogers Erica J.President and CEOApr 12Option Exercise1.6011,00017,600142,221Apr 14 08:02 PM
Rogers Erica J.President and CEOApr 12Sale49.7311,000547,067131,616Apr 14 08:02 PM
Davis Andrew S.Chief Commercial OfficerApr 05Sale51.1666033,76731,240Apr 06 08:57 PM
Davis Andrew S.Chief Commercial OfficerApr 01Option Exercise1.606,32410,11838,224Apr 02 09:25 PM
Davis Andrew S.Chief Commercial OfficerApr 01Sale50.866,324321,65431,900Apr 02 09:25 PM
Buchanan Lucas W.COO/CFOMar 29Option Exercise12.1510,000121,500186,347Mar 31 08:00 PM
Buchanan Lucas W.COO/CFOMar 29Sale46.7310,000467,258176,772Mar 31 08:00 PM
Rogers Erica J.President and CEOMar 11Option Exercise1.6011,00017,600142,616Mar 12 06:14 PM
Rogers Erica J.President and CEOMar 11Sale52.9611,000582,518131,616Mar 12 06:14 PM
Davis Andrew S.Chief Commercial OfficerMar 01Option Exercise1.467,47210,90927,274Mar 02 09:32 PM
Davis Andrew S.Chief Commercial OfficerMar 01Sale56.497,472422,12519,802Mar 02 09:32 PM
Buchanan Lucas W.COO/CFOFeb 24Option Exercise10.2810,000102,845171,902Feb 25 06:25 PM
Buchanan Lucas W.COO/CFOFeb 24Sale53.6410,000536,353164,606Feb 25 06:25 PM
Buchanan Lucas W.COO/CFOFeb 17Option Exercise1.6010,00016,000164,606Feb 19 06:16 PM
Rogers Erica J.President and CEOFeb 11Option Exercise1.6011,00017,600122,608Feb 12 07:38 PM
Rogers Erica J.President and CEOFeb 11Sale59.5511,000655,058111,608Feb 12 07:38 PM
Davis Andrew S.Chief Commercial OfficerFeb 01Option Exercise1.467,47210,90927,274Feb 02 06:17 PM
Davis Andrew S.Chief Commercial OfficerFeb 01Sale54.127,472404,39219,802Feb 02 06:17 PM
Buchanan Lucas W.COO/CFOJan 27Option Exercise4.7310,00047,300164,606Jan 29 06:03 PM
Buchanan Lucas W.COO/CFOJan 27Sale54.8610,000548,623154,606Jan 29 06:03 PM
Rogers Erica J.President and CEOJan 11Option Exercise1.6011,00017,600122,608Jan 13 09:03 PM
Rogers Erica J.President and CEOJan 11Sale59.6611,000656,291111,608Jan 13 09:03 PM
Davis Andrew S.Chief Commercial OfficerJan 04Option Exercise1.467,47210,90927,274Jan 05 08:28 PM
Davis Andrew S.Chief Commercial OfficerJan 04Sale59.677,472445,86719,802Jan 05 08:28 PM
Buchanan Lucas W.COO/CFODec 29Option Exercise3.3418,00060,100156,606Dec 30 09:08 PM
Buchanan Lucas W.COO/CFODec 29Sale60.0410,000600,364146,606Dec 30 09:08 PM
Buchanan Lucas W.COO/CFODec 14Option Exercise1.607,00011,200146,606Dec 15 06:57 PM
Buchanan Lucas W.COO/CFODec 11Option Exercise1.607,00011,200139,606Dec 15 06:57 PM
Rogers Erica J.President and CEODec 11Option Exercise1.4911,00016,400120,180Dec 15 06:16 PM
Rogers Erica J.President and CEODec 11Sale58.3511,000641,866111,608Dec 15 06:16 PM
Davis Andrew S.Chief Commercial OfficerDec 01Option Exercise1.467,47210,90927,274Dec 03 06:59 PM
Davis Andrew S.Chief Commercial OfficerDec 01Sale56.637,472423,11219,802Dec 03 06:59 PM
Buchanan Lucas W.COO/CFONov 25Option Exercise4.7310,00047,300142,523Nov 30 05:48 PM
Buchanan Lucas W.COO/CFONov 25Sale57.0810,000570,826132,523Nov 30 05:48 PM
Ruedy RichardEVPClin&Reg.Affairs&QANov 23Option Exercise1.57108,974171,478128,118Nov 24 05:42 PM
Ruedy RichardEVPClin&Reg.Affairs&QANov 17Option Exercise1.4214,22120,21826,551Nov 18 06:20 PM
Ruedy RichardEVPClin&Reg.Affairs&QANov 17Sale59.8414,221850,97219,144Nov 18 06:20 PM
Rogers Erica J.President and CEONov 11Option Exercise1.4611,00016,060122,608Nov 13 08:22 PM
Rogers Erica J.President and CEONov 11Sale63.4411,000697,820111,608Nov 13 08:22 PM
Davis Andrew S.Chief Commercial OfficerNov 02Option Exercise1.466,6409,69426,442Nov 04 06:51 PM
Davis Andrew S.Chief Commercial OfficerNov 02Sale61.376,640407,48419,802Nov 04 06:51 PM
Buchanan Lucas W.COO/CFOOct 14Option Exercise4.739,60045,408117,898Oct 16 06:38 PM
Buchanan Lucas W.COO/CFOOct 14Sale65.219,600626,020111,027Oct 16 06:38 PM
Rogers Erica J.President and CEOOct 12Option Exercise1.4620,04429,264131,652Oct 13 06:11 PM
Rogers Erica J.President and CEOOct 12Sale66.1620,0441,326,133111,608Oct 13 06:11 PM
Davis Andrew S.Chief Commercial OfficerOct 01Option Exercise1.466,6359,68726,437Oct 02 05:37 PM
Davis Andrew S.Chief Commercial OfficerOct 01Sale65.606,635435,23919,802Oct 02 05:37 PM
Buchanan Lucas W.Chief Financial OfficerSep 17Option Exercise4.739,60045,408120,627Sep 18 07:36 PM
Buchanan Lucas W.Chief Financial OfficerSep 17Sale67.329,600646,284111,027Sep 18 07:36 PM
Rogers Erica J.President and CEOSep 11Option Exercise1.4520,04428,971127,982Sep 15 06:17 PM
Rogers Erica J.President and CEOSep 11Sale60.9820,0441,222,347111,608Sep 15 06:17 PM
Davis Andrew S.Chief Commercial OfficerSep 01Option Exercise1.466,6359,68726,437Sep 02 05:46 PM
Davis Andrew S.Chief Commercial OfficerSep 01Sale59.726,635396,26219,802Sep 02 05:46 PM
Buchanan Lucas W.Chief Financial OfficerAug 17Option Exercise3.979,60038,143118,306Aug 19 06:31 PM
Buchanan Lucas W.Chief Financial OfficerAug 17Sale53.869,600517,097111,027Aug 19 06:31 PM
Rogers Erica J.President and CEOAug 11Option Exercise1.3820,04427,661131,652Aug 12 07:01 PM
Rogers Erica J.President and CEOAug 11Sale51.4220,0441,030,616111,608Aug 12 07:01 PM
Davis Andrew S.Chief Commercial OfficerAug 03Option Exercise1.466,6359,68725,537Aug 04 05:59 PM
Davis Andrew S.Chief Commercial OfficerAug 03Sale47.796,635317,10218,902Aug 04 05:59 PM
Buchanan Lucas W.Chief Financial OfficerJul 15Option Exercise1.609,60015,360120,627Jul 16 05:38 PM
Buchanan Lucas W.Chief Financial OfficerJul 15Sale45.999,600441,540111,027Jul 16 05:38 PM
Rogers Erica J.President and CEOJul 13Option Exercise1.3820,04427,661131,652Jul 14 07:26 PM
Rogers Erica J.President and CEOJul 13Sale45.4220,044910,443111,608Jul 14 07:26 PM
Davis Andrew S.EVPGlobal Sales& MarketingJul 01Option Exercise1.466,6359,68725,537Jul 06 05:51 PM
Davis Andrew S.EVPGlobal Sales& MarketingJul 01Sale41.956,635278,34318,902Jul 06 05:51 PM
Buchanan Lucas W.Chief Financial OfficerJun 15Option Exercise1.609,60015,360116,016Jun 16 07:27 PM
Buchanan Lucas W.Chief Financial OfficerJun 15Sale36.979,600354,875110,358Jun 16 07:27 PM